...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Reperfusion of pulmonary arteriovenous malformations after embolotherapy.
【24h】

Reperfusion of pulmonary arteriovenous malformations after embolotherapy.

机译:栓塞治疗后肺动静脉畸形的再灌注。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To describe the mechanisms and risk factors associated with reperfusion of successfully treated pulmonary arteriovenous malformations (PAVMs) after embolotherapy. MATERIALS AND METHODS: Among 112 consecutive patients with PAVMs treated by embolotherapy, 19 patients were identified who had 33 angiographically confirmed reperfused PAVMs. A retrospective analysis of computed tomography (CT) and angiography was performed in patients with documented reperfused PAVMs in which reperfused PAVMs were compared with nonreperfused PAVMs. CT images were examined for persistence of the aneurysm and/or draining vein after initial embolotherapy and correlated with angiography to determine the mechanism of reperfusion. PAVM and embolic agent characteristics (eg, feeding artery size and number; PAVM location; coil size, number, and location) were evaluated for association with reperfusion. The outcomes of repeat embolotherapy for reperfused PAVMs were evaluated. RESULTS: The PAVM aneurysm and/or draining vein persisted on CT after initial embolotherapy in all reperfused PAVMs and resolved in all nonreperfused PAVMs (in patients with nondiffuse PAVMs). Recanalization was the mechanism of reperfusion in 88%. Reperfusion was associated with the use of a single coil (P < .0001), oversized coils (P < .0001), coil placement more than 1 cm from the aneurysm (P < .0001), and increased feeding artery size (P < .001). Repeat embolotherapy for reperfused PAVMs was technically successful in 94% of cases. In the remaining 6% of cases, insufficient feeding artery length prevented safe repeat treatment. After a mean follow-up of 41 months, 42% of reperfused PAVMs in our series have been successfully treated again and occluded. CONCLUSIONS: Recanalization is the most common mechanism of PAVM reperfusion. Increased feeding artery diameter, low number of coils, use of oversized coils, and proximal coil placement within the feeding artery are associated with reperfusion. Distal coil placement facilitates repeat embolization if reperfusion occurs.
机译:目的:描述栓塞治疗后成功治疗的肺动静脉畸形(PAVM)再灌注相关的机制和危险因素。材料与方法:在连续112例接受栓子治疗的PAVM患者中,有19例经血管造影证实为再灌注PAVM的患者为19例。对有记录的再灌注PAVM的患者进行了计算机断层扫描(CT)和血管造影的回顾性分析,其中将再灌注PAVM与未再灌注PAVM进行了比较。初次栓塞治疗后检查CT图像是否存在动脉瘤和/或引流静脉,并与血管造影相关以确定再灌注机制。评估了PAVM和栓塞剂的特性(例如,进食动脉的大小和数量; PAVM的位置;线圈的大小,数量和位置)与再灌注的相关性。评估了再灌注PAVM栓塞治疗的结果。结果:所有再灌注的PAVM中,初次栓塞治疗后,PAVM的动脉瘤和/或引流静脉在CT上持续存在,而在所有非再灌注的PAVM中(非弥散性PAVM的患者),PAVM的动脉瘤和/或引流静脉均持续。再通是88%再灌注的机制。再灌注与使用单个线圈(P <.0001),线圈过大(P <.0001),线圈距动脉瘤超过1 cm(P <.0001)以及进食动脉尺寸增加(P < .001)。对于再灌注的PAVM,重复栓塞治疗在94%的病例中在技术上是成功的。在剩余的6%病例中,饲喂动脉长度不足阻止了安全的重复治疗。在平均随访41个月后,我们系列中再灌注PAVM的42%已被成功再次治疗并闭塞。结论:再通是PAVM再灌注的最常见机制。饲喂动脉直径增加,线圈数量少,使用超大线圈以及在饲喂动脉内近端线圈放置与再灌注有关。如果发生再灌注,远端线圈的放置有助于重复栓塞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号